AMP Releases Best Practices Report for SARS-CoV-2 Genomic Surveillance Using NGS Tech
The AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
Read MorePosted by Andy Lundin | Nov 13, 2024 | Covid 19 |
The AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
Read MorePosted by Andy Lundin | Nov 12, 2024 | Sequencing Systems |
A mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Covid 19 |
Nasal autoantibodies can predict COVID severity, providing insights for personalized treatment and applications for other respiratory viruses.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Covid 19 |
Researchers developed a new surveillance technique that can detect emerging COVID variants before they become widespread.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Emerging & Zoonotic Diseases |
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Read More